Pub. Date : 2020 Feb
PMID : 31673875
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | CONCLUSION: Coadministration of fluconazole or itraconazole or other moderate/strong CYP2C9 or CYP3A4 inhibitors may increase exposure to erdafitinib in healthy adults and thus may warrant erdafitinib dose reduction or use of alternative concomitant medications with no or minimal CYP2C9 or CYP3A4 inhibition potential. | Itraconazole | cytochrome P450 family 3 subfamily A member 4 | Homo sapiens |